Decreased TET2 promoter CGI methylation was observed in NHL cases compared to controls (Figure 4E, p = 0.0159), and between healthy controls and FL subtype (Figure 4F, p = 0.0210). The gene discussed is TET2; the disease is non-Hodgkin lymphoma.